Insider · CIK 0001589776
Marco Maria Brughera
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing Sep 16, 2026, latest Sep 16, 2026.
In brief
Marco Maria Brughera files SEC Form 4 as director at FENC (FENNEC PHARMACEUTICALS INC.). Since Sep 16, 2026, Marco Maria Brughera has reported 0 open-market buys worth $0 and 1 open-market sell worth $160k, the latest filed on Sep 16, 2026.
A track record needs three past buys with six months of prices behind them; Marco Maria Brughera has 0, so none is measured yet.
The newest scored trade: sold $160k of FENC on Sep 15, 2026, filed Sep 16, 2026, scored 19 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $160k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FENC: FENNEC PHARMACEUTICALS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | FENNEC PHARMACEUTICALS INC. | $160k 15,545 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 15, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 15,545 0.04% of outstanding | $160k | Sep 15, 2026 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +15,545 | $2.11 | $33k | 15,545 | 27 d ago |
| Sep 15, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -15,545 | $10.29 | $160k | 0 | 27 d ago |
| Sep 15, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionderivative10b5-1 | -15,545 | $0.00 | $0 | 220,000 | 27 d ago |
| Jun 10, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionderivative | +20,000 | $8.70 | $174k | 235,545 | Jun 10, 2026 |
| Jun 3, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionderivative | +20,000 | $7.88 | $158k | 215,545 | Jun 4, 2025 |
Questions about Marco Maria Brughera
Answered from the filings on this page, as of the latest one.
Is Marco Maria Brughera buying or selling?
In the last 12 months Marco Maria Brughera reported 0 open-market buys worth $0 and 1 open-market sell worth $160k on SEC Form 4; the latest was sold $160k of FENC on Sep 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Marco Maria Brughera's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marco Maria Brughera has 0.
Where does Marco Maria Brughera file Form 4?
Marco Maria Brughera has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.